Skip to main content

Connective tissue diseases

Epidemiology

Rituximab and rheumatology practice in the COVID-19 era

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of SLE

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

New additions to the Adis Journal Club

Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

ACR Convergence 2021

3–9 November: Keep up with the latest news and interviews from the conference.

Febuxostat and cardiovascular risk in people with gout

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Telemedicine in rheumatology

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Get ready for ACR Convergence 2020

ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

15-07-2018 | Epidemiology | Article

Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome

Alharbi S et al. J Rheumatol 2018. doi: 10.3899/jrheum.170953

11-07-2018 | Systemic lupus erythematosus | Article

Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients

Hax V et al. Adv Rheumatol 2018; 58: 12. doi: 10.1186/s42358-018-0003-2

11-07-2018 | Systemic sclerosis | News

SSc more common in UK than previously thought

Results of a nationwide study suggest that the incidence and prevalence of systemic sclerosis in the UK may be higher than previous estimates suggest.

10-07-2018 | Pediatric | Article

Adverse childhood experience and rheumatic diseases

Luiz APL et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4200-5

09-07-2018 | Systemic lupus erythematosus | Article

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada

Fatoye F, Gebrye T, Svenson LW. Rheumatol Int 2018. doi: 10.1007/s00296-018-4091-4

02-06-2018 | Systemic sclerosis | Article

Mortality, length of stay, and cost of hospitalization among patients with systemic sclerosis: Results from the National Inpatient Sample

Poudel DR et al. Rheumatology (Oxford) 2018: key150. doi: 10.1093/rheumatology/key150

01-06-2018 | Systemic lupus erythematosus | Article

Monophasic disease course in systemic lupus erythematosus

Tselios K et al. J Rheumatol 2018. doi: 10.3899/jrheum.171319